Literature DB >> 8144947

In vivo activation of naive T cells by antigen-presenting B cells.

S C Morris1, A Lees, F D Finkelman.   

Abstract

In vivo experiments were performed to determine if the cross-linking of mlg on antigen-presenting B cells could induce them to present Ag to naive T cells in a stimulatory rather than a tolerogenic fashion. Mice were injected with a foreign mAb to a B cell Ag (Fc epsilon RII or CR1), and/or a self-anti-IgD mAb. Injection of either mAb alone failed to induce an Ab response; however, simultaneous injection of the foreign anti-B cell mAb plus the self-anti-IgD mAb stimulated a large response. Inasmuch as injection of the anti-IgD mAb should not have facilitated transfer of the foreign mAb to dendritic cells, this observation suggests that cross-linking of B cell mlg can induce B cells to acquire the ability to present Ag to naive T cells in an activating manner. Furthermore, when injected with anti-IgD mAb, both foreign anti-B cell mAbs were more potent in inducing Ab responses in this system than were isotype-matched control mAbs, consistent with the hypothesis that T cells were activated by Ag-presenting B cells. Results of dose-response and cell transfer studies, however, suggested that stringent cross-linking of B cell mlg on large numbers of B cells is required for B cell Ag presentation to induce T cell activation rather than tolerance. Therefore, these observations suggest that professional APCs usually are required to activate naive T cells, and that B cell Ag presentation can only activate naive T cells under unusual circumstances.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8144947

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

1.  Pathogenesis of herpes simplex virus-induced ocular immunoinflammatory lesions in B-cell-deficient mice.

Authors:  S P Deshpande; M Zheng; M Daheshia; B T Rouse
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  A viral protein that selectively downregulates ICAM-1 and B7-2 and modulates T cell costimulation.

Authors:  L Coscoy; D Ganem
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

Review 3.  Role of B7 signaling in the differentiation of naive CD4+ T cells to effector interleukin-4-producing T helper cells.

Authors:  W C Gause; J F Urban; P Linsley; P Lu
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

4.  The Mertk receptor tyrosine kinase promotes T-B interaction stimulated by IgD B-cell receptor cross-linking.

Authors:  Wen-Hai Shao; Yuxuan Zhen; Fred D Finkelman; Philip L Cohen
Journal:  J Autoimmun       Date:  2014-04-24       Impact factor: 7.094

5.  Graft-versus-host disease: part I. Pathogenesis and clinical manifestations of graft-versus-host disease.

Authors:  Sharon R Hymes; Amin M Alousi; Edward W Cowen
Journal:  J Am Acad Dermatol       Date:  2012-04       Impact factor: 11.527

6.  Lack of mature lymphocytes results in obese but metabolically healthy mice when fed a high-fat diet.

Authors:  X Liu; J Y Huh; H Gong; J P Chamberland; M T Brinkoetter; O-P R Hamnvik; C S Mantzoros
Journal:  Int J Obes (Lond)       Date:  2015-05-21       Impact factor: 5.095

7.  CD81 on B cells promotes interleukin 4 secretion and antibody production during T helper type 2 immune responses.

Authors:  H T Maecker; M S Do; S Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

Review 8.  Heparin-induced thrombocytopenia: molecular pathogenesis.

Authors:  Seon Ho Lee; Chao Yan Liu; Gian PaoloVisentin
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

9.  Targeting of antigens to B cells augments antigen-specific T-cell responses and breaks immune tolerance to tumor-associated antigen MUC1.

Authors:  Chuanlin Ding; Li Wang; Jose Marroquin; Jun Yan
Journal:  Blood       Date:  2008-07-31       Impact factor: 22.113

10.  The modulatory effects of lipopolysaccharide-stimulated B cells on differential T-cell polarization.

Authors:  Hui Xu; Lip Nyin Liew; I Chun Kuo; Chiung Hui Huang; Denise Li-Meng Goh; Kaw Yan Chua
Journal:  Immunology       Date:  2008-03-18       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.